Nuformix PLC (LSX:A141LG) Financings

Nuformix PLC

Financings

RaiseDateIn US dollars
Rights offering of open Offer Shares (ordinary shares)
Announced: about £228,081 · GBX 0.2 a share · CMC Markets UK Plc
Dealers: CMC Markets UK Plc
Use of proceeds: Assess NXP002's inhaled therapeutic window, support partnering and out-licensing talks, maintain key IP, and working capital
Oct 28, 2025US$302,850
Private placement of new ordinary shares
Update: £210,000 · GBX 0.07 a share · CMC Markets UK Plc
Dealers: CMC Markets UK Plc
May 23, 2025US$283,766
Warrant exercise of new ordinary shares
Announced: £13,200 · GBX 0.05 a share
Apr 14, 2025US$17,392
Private placement of new ordinary shares
Announced: £168,750 · GBX 0.0675 a share · CMC Markets UK Plc, trading as CMC CapX
Dealers: CMC Markets UK Plc, trading as CMC CapX (lead)
Use of proceeds: Progress partnering discussions for NXP002 inhaled IPF/PPF programme and general corporate purposes
Jan 30, 2025US$210,182

Read by 6ix AI from the company's releases